Literature DB >> 23775011

Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case-control studies.

Wen Feng Yan1, Pei Chun Sun, Chang Fu Nie, Gang Wu.   

Abstract

The associations between cyclooxygenase-2 (COX-2) polymorphisms (-765G>C, -1195G>A, and -587G>A) and risk of gastric cancer have been investigated, but the results were inconsistent. The aim of this study was to explore the associations between COX-2 polymorphisms and risk of gastric cancer using a meta-analytic method. We searched the databases of PubMed, Embase, and Wanfang (Chinese database) to identify the eligible studies. Odds ratio and 95 % confidence interval (OR and 95% CI) were used as effect size, and combined analyses were conducted using fixed- or random-effects model. Overall, ten studies for COX-2-765G>C, six studies for -1195G>A, and three studies for -587G>A were included in this study. The results for combined analysis for COX-2-765G>C indicated that C allele was significantly associated with increased risk of gastric cancer compared with G allele, especially for Asians (OR and 95 % CI: 1.58 (1.06-2.35), P(z-test) = 0.03, and P heterogeneity <0.01 for CC+GC vs. GG). In addition, the A allele of COX-2-1195G>A was also significantly associated with risk of gastric cancer compared with G allele (OR and 95 % CI: 1.20 (1.09-1.32), P(z-test) <0.001, and P(heterogeneity) = 0.82 for A carriers vs. G carriers). In contrast, the COX-2-587G>A polymorphism was not associated with risks of gastric cancer. In summary, this meta-analysis indicated that the COX-2-765G>C and -1195G>A polymorphisms were significantly associated with risk of gastric cancer development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775011     DOI: 10.1007/s13277-013-0901-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology.

Authors:  John Attia; Ammarin Thakkinstian; Catherine D'Este
Journal:  J Clin Epidemiol       Date:  2003-04       Impact factor: 6.437

Review 2.  A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research.

Authors:  Stefania Boccia; Emma De Feo; Paola Gallì; Francesco Gianfagna; Rosarita Amore; Gualtiero Ricciardi
Journal:  Eur J Epidemiol       Date:  2010-09-10       Impact factor: 8.082

3.  COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.

Authors:  Juliët H Hoff; Rene H M te Morsche; Hennie M J Roelofs; Elise M J van der Logt; Fokko M Nagengast; Wilbert H M Peters
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

4.  [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].

Authors:  Xue-mei Zhang; Xiao-ping Miao; Wen Tan; Tong Sun; Yong-li Guo; Dan Zhao; Dong-xin Lin
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2006-04

5.  Study on the association of COX-2 genetic polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu province in China.

Authors:  Zhu Ke-Xiang; Li Yu-Min; Li Xun; Zhou Wen-Ce; Shan Yong; Liu Tao
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

6.  Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.

Authors:  Chiung-Nien Chen; Fon-Jou Hsieh; Yunn-Ming Cheng; King-Jen Chang; Po-Huang Lee
Journal:  J Surg Oncol       Date:  2006-09-01       Impact factor: 3.454

7.  p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies.

Authors:  Fei Liu; Liu Liu; Bo Li; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen; Ming-Qing Xu; Wen-Tao Wang; Jia-Yin Yang
Journal:  Mutagenesis       Date:  2011-04-18       Impact factor: 3.000

Review 8.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

9.  Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.

Authors:  Yuan Liang; Jia-Li Liu; Yan Wu; Zhen-Yong Zhang; Rong Wu
Journal:  Tohoku J Exp Med       Date:  2011-02       Impact factor: 1.848

10.  The COX-2 promoter polymorphism -765 G>C is associated with early-onset, conventional and stump gastric cancers.

Authors:  Robert Sitarz; Roos J Leguit; Wendy W J de Leng; Mirjam Polak; Folkert M Morsink; Onno Bakker; Ryszard Maciejewski; G Johan A Offerhaus; Anya N Milne
Journal:  Mod Pathol       Date:  2008-02-29       Impact factor: 7.842

View more
  5 in total

1.  Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.

Authors:  Yafeng Wang; Heping Jiang; Tianyun Liu; Weifeng Tang; Zhiqiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data.

Authors:  Wei-Dong Leng; Xiu-Jie Wen; Joey S W Kwong; Wei Huang; Jian-Gang Chen; Xian-Tao Zeng
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

3.  Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies.

Authors:  Jie Tian; Guanchu Liu; Chunjian Zuo; Caiyang Liu; Wanlun He; Huanwen Chen
Journal:  Cancer Biol Med       Date:  2019-05       Impact factor: 5.347

4.  Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer.

Authors:  Qinghong Guo; Xiaojun Liu; Linzhi Lu; Hao Yuan; Yuping Wang; Zhaofeng Chen; Rui Ji; Yongning Zhou
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

5.  COX-2 gene expression and methylation profile in Sapajus apella as an experimental model for gastric adenocarcinoma.

Authors:  Danilo do Rosário Pinheiro; Maria Lucia Harada; Rommel Mario Rodriguez Burbano; Barbara do Nascimento Borges
Journal:  Genet Mol Biol       Date:  2018-05-14       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.